Abiopharma

News list

MEHTA SAMIR 🟢 acquired 18.0K shares (1 derivative) of L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX) Transaction Date: Aug 03, 2026 | Filing ID: 000012

Full text

News bot Aug. 3, 2026, 11:15 p.m.
🔍 MEHTA SAMIR (Executive)

Company: L3HARRIS TECHNOLOGIES, INC. /DE/ (LHX)

Report Date: 2026-08-03
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 17,995
Detailed Transactions and Holdings:
- Acquired 17,995 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-03 | Code: A | equity_swap_involved: 0 | shares_owned_after: 17,995.00 | transaction_form_type: 4 | Footnotes: F1, F1
Footnotes:
- F1: Award of restricted stock units subject to 3-year cliff vesting upon fiscal 2029 year-end, subject to continued employment (with certain exceptions) and the terms and conditions of the restricted unit award agreement. Each restricted stock unit represents a contingent right to one share of the Issuer's common stock, with vested units settled in shares of the Issuer's common stock.